Curanex Pharmaceuticals Inc Common Stock financial statements

큐러넥스 파머슈티컬스NASDAQ:CURX · Nasdaq
$4.99+0.60%
2026-10-06 close · prelim

Curanex Pharmaceuticals Inc Common Stock's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was $0M.

Reported results

Curanex Pharmaceuticals Inc Common Stock notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q